Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Vivimed Labs Ltd

Vivimed Labs Ltd share price and stock overview

Vivimed Labs Ltd (NSE: VIVIMEDLAB, BSE: 532660) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE526G01021 and a face value of Rs 2. As of 26 July 2026, it trades at Rs (5.18) with a market capitalisation of Rs 43.94 crore. Figures are live and subject to change.

Vivimed Labs Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
5.18 0.01 (0.19%) upARrowC
As on: 26-Jul-2026 , 10:37 AM
Market Cap(₹Cr) 43.94
Book Value(₹Cr) -18.1148384
BSE Code : 532660 NSE Symbol : VIVIMEDLAB EPS(TTM) : 0 ISIN Demat : INE526G01021 P/E(TTM) : 0 Face Value(₹) : 2 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

76,210.95

Todday's Low

75,474.43

Open at

75,708.19

Previous Close

76,391.39

Volumes

Avg Price

-331.62

Historical Performance

News

15 Jul 26
Vivimed Labs to table results
Vivimed Labs will hold a meeting of the Board of Directors of the Company on 17 July 2026.
18 May 26
Vivimed Labs to convene board meeting
Vivimed Labs will hold a meeting of the Board of Directors of the Company on 28 May 2026.
14 Mar 26
Vivimed Labs reports consolidated net loss of Rs 16.55 crore in the December 2025 quarter
Net Loss of Vivimed Labs reported to Rs 16.55 crore in the quarter ended December 2025 as against net loss of Rs 5.
10 Mar 26
Vivimed Labs to table results
Vivimed Labs will hold a meeting of the Board of Directors of the Company on 13 March 2026.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
24-07-26 5.17 5.25 5.11 5.18 31017 79 160205.83 23767.45
23-07-26 5.03 5.30 5.03 5.17 23280 72 120085.63 23869.60
22-07-26 5.25 5.34 5.05 5.11 50972 108 263967.00 23996.25
21-07-26 5.15 5.35 5.05 5.13 25738 86 132097.62 24187.70
20-07-26 5.45 5.45 5.02 5.26 50502 105 261636.42 24238.50
17-07-26 5.13 5.33 5.09 5.23 59908 155 314714.19 24334.30
16-07-26 5.22 5.22 5.05 5.08 70365 146 360501.40 24072.75
15-07-26 5.35 5.35 5.10 5.22 46591 152 241963.32 24078.50
14-07-26 5.15 5.40 5.15 5.25 75409 134 394615.98 24052.05
13-07-26 5.67 5.67 5.31 5.36 91175 132 492811.30 24211.00
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

43.94

PE Ratio

0

PB Ratio

-0.29

Dividend Yield

0

ROE

0.00

ROCE

0.00

Book Value (₹)

-18.1148384

Face Value (₹)

2

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 434450 0.52 434450 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5844330 7.05 5844330 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6278780 7.57 6278780 14
Total ShareHolding for Promoter & Group 6278780 7.57 6278780 14
plus   Publice Share Holding
plus  Institution
Government(Central / State) 96130 0.12 96130 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1362919 1.64 1362919 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1459049 1.76 1459049 6
plus  Non Institution
Bodies Corporate 5333831 6.43 5333831 207
Clearing Members 5585 0.01 5585 2
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 5017762 6.05 3647922 449
Foreign Non Institution Other 7766387 9.37 7766387 1
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9336978 11.26 9336978 40
Individuals holding nominal share capital up to Rs. 1 lakh 47668921 57.49 47653204 46770
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5050 0.01 5050 2
Others 41572 0.05 41572 1
Sub Total 75176086 90.67 73790529 47472
Total Public Shareholding 76635135 92.43 75249578 47478
Total of Promoter & Public ShareHolding 82913915 100.00 81528358 47492
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 82913915 100.00 81528358 47492

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Net Sales116.27149.07187.10237.29861.47
OPM (%)-27.39-30.74-176.73-27.32-8.11
OP-31.85-45.82-330.65-64.83-69.86
Other Income4.379.980.971.279.82
PBIDT-8.68-23.45-186.34-6.7939.51
INTEREST2.952.4335.9039.7653.88
PBDT-11.62-25.88-222.25-46.55-14.36
PBT-31.85-45.82-330.65-64.83-69.86
EO0.000.000.000.000.00
PBT after EO-31.85-45.82-330.65-64.83-69.86
TAXES0.11-0.38-2.122.822.03
PAT-31.96-45.45-328.54-67.65-71.89
EPS-3.74-5.32-38.46-7.92-8.42
Raw Material49.6860.07111.6464.4841.54
Power and Fuel3.413.604.882.493.89
Employee Cost24.4222.9117.4615.2722.03
Other Manufacturing Expenses1.703.163.181.9410.07
Selling and Administration Expenses24.9418.7020.5511.6610.61
Miscellaneous Expenses0.1821.950.510.101.27
Revenue (Growth %) -22.00-20.33-21.15-72.46-18.64
PBIDT (Growth %)-63.00-87.422,644.37-117.18141.48
PAT (Growth %) -29.67-86.17385.64-5.89-34.12
PBIDT (Margin %)-7.46-15.73-99.60-2.864.59
PAT (Margin %) -27.49-30.49-175.59-28.51-8.34

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital 16.5816.5816.5816.5816.5816.58
Reserves Total 41.9172.83116.73440.69507.88537.31
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds58.4989.41133.31457.27524.46553.89
Secured Loans 311.51312.16314.66296.33267.10200.03
Unsecured Loans 63.3263.3261.9860.6156.27103.80
Total Debt374.83375.48376.64356.94323.37303.83
Other Liabilities114.91128.54179.00176.93174.93135.75
Total Liabilities548.23593.43688.95991.141022.76993.47
APPLICATION OF FUNDS :
Gross Block 514.50506.90505.03565.73536.00460.09
Less : Accumulated Depreciation 199.22180.58162.17136.92119.50103.68
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 315.28326.32342.86428.81416.50356.41
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress17.1120.6520.6740.0358.4569.77
Producing Properties0.000.000.000.000.000.00
Investments 58.7858.78161.14161.14161.1487.50
Current Assets, Loans & Advances
Inventories 56.5062.7778.31239.07253.68263.37
Sundry Debtors 45.8059.5450.3063.3976.7089.67
Cash and Bank Balance0.291.143.356.786.0211.09
Loans and Advances 145.19152.27139.20132.58122.35189.51
Total Current Assets247.78275.72271.16441.82458.75553.63
Less : Current Liabilities and Provisions
Current Liabilities 62.2959.7678.4750.6244.2644.88
Provisions 19.4119.2619.3618.8719.4720.41
Total Current Liabilities & Provisions81.7079.0297.8369.4963.7365.29
Net Current Assets166.07196.70173.33372.32395.02488.34
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets0.000.000.000.000.000.00
Deferred Tax Liability9.039.039.0311.158.338.57
Net Deferred Tax-9.03-9.03-9.03-11.15-8.33-8.57
Other Assets0.000.000.000.000.000.00
Total Assets548.21593.42688.97991.151022.78993.45
Contingent Liabilities182.79115.69122.93215.57220.6611.54

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities -46.40-13.21-34.70-5.51-2.53
Investing Activities -138.20-11.34-1.6099.83-4.06
Net Cash Flow -5.070.76-3.43-2.20-0.86
Operating Activities 179.5225.3132.87-96.525.73

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
VMR
V Manohar Rao
Chairman & Wholetime Director
Executive
Functional Directors
SV
Santosh Varalwar
Executive Director & MD
Exec.
Independent Directors
SV
Sandeep Varalwar
Independent Non Exe. Director
Ind.
AB
Aparna Bidarkar
Independent Non Exe. Director
Ind.
SP
Subbarathnamma PalepU
Independent Non Exe. Director
Ind.
JSP
Jarugula Siva Prasad
Independent Non Exe. Director
Ind.
Other Officials
YK
Yugandhar Kopparthi
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Vivimed Labs Ltd? −

Vivimed Labs Ltd trades on NSE under VIVIMEDLAB and on BSE under code 532660. The ISIN is INE526G01021 and the face value is Rs 2.

What is the share price of Vivimed Labs Ltd today? +

As of 26 July 2026, Vivimed Labs Ltd trades at Rs 5.18, a change of 0.01 (0.19%) on the day. Prices are live and subject to change.

What is the market capitalisation of Vivimed Labs Ltd? +

As of 26 July 2026, Vivimed Labs Ltd has a market cap of about Rs 43.94 crore. This figure is live and moves with the share price.

Is Vivimed Labs Ltd profitable? +

In March 2025, Vivimed Labs Ltd reported a profit after tax of Rs -31.96 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Vivimed Labs Ltd? +

: As of 26 July 2026, the PE (TTM) for Vivimed Labs Ltd is 0 and the price-to-book ratio is -0.29. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Vivimed Labs Ltd pay a dividend? +

As of 26 July 2026, the dividend yield for Vivimed Labs Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Vivimed Labs Ltd? +

As of the latest disclosed pattern, promoters hold 7.57% of Vivimed Labs Ltd. Public shareholding is 92.43%, including mutual funds at 0.00% and foreign institutional investors at 1.64%.

What were the latest annual financials of Vivimed Labs Ltd? +

In March 2025, Vivimed Labs Ltd reported net sales of Rs 116.27 crore, revenue growth of -22.00%, and earnings per share of Rs -3.74.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web